Evidence map›Paper›PMID 41578731›Full record

ArticleAmerican journal of medical genetics. Part A2026

Wide Ranging Neurobehavioral Phenotype in Individuals With Costello Syndrome.

Millicent S Curlee, Atara Siegel, Paige Little, Mary Anne Toledo-Tamula, Staci Martin, Andrea M Gross, Marielle E Yohe, Margarita Aryavand, Megan N Frone, Gina M Ney and 2 more

Abstract readCase Reports
In one paragraph

Article in American journal of medical genetics. Part A, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Millicent S CurleeCenter for Cancer Research, Pediatric Oncology Branch, National Cancer Institute, USA.ORCID 0000-0003-1925-0520
Atara SiegelCenter for Cancer Research, Pediatric Oncology Branch, National Cancer Institute, USA.ORCID 0000-0001-6447-0392
Paige LittleCenter for Cancer Research, Pediatric Oncology Branch, National Cancer Institute, USA.ORCID 0009-0001-1888-1585
Mary Anne Toledo-TamulaCenter for Cancer Research, Pediatric Oncology Branch, National Cancer Institute, USA.ORCID 0009-0009-9253-0642
Staci MartinCenter for Cancer Research, Pediatric Oncology Branch, National Cancer Institute, USA.ORCID 0000-0002-9342-4173
Andrea M GrossCenter for Cancer Research, Pediatric Oncology Branch, National Cancer Institute, USA.ORCID 0000-0003-1646-4531
Marielle E YoheCenter for Cancer Research, Pediatric Oncology Branch, National Cancer Institute, USA.ORCID 0000-0001-5356-9426
Margarita AryavandDivision of Cancer Epidemiology & Genetics, Clinical Genetics Branch, National Cancer Institute, USA.
Megan N FroneDivision of Cancer Epidemiology & Genetics, Clinical Genetics Branch, National Cancer Institute, USA.ORCID 0000-0001-8273-8866
Gina M NeyDivision of Cancer Epidemiology & Genetics, Clinical Genetics Branch, National Cancer Institute, USA.ORCID 0000-0002-6530-780X
Douglas R StewartDivision of Cancer Epidemiology & Genetics, Clinical Genetics Branch, National Cancer Institute, USA.ORCID 0000-0001-8193-1488
Pamela L WoltersCenter for Cancer Research, Pediatric Oncology Branch, National Cancer Institute, USA.ORCID 0000-0001-9319-6281

Funding

Intramural NIH HHS Z99 CA999999Intramural Research Program of the National Institutes of Health, Divisions of Cancer Epidemiology and Genetics and the Center for Cancer Research of the National Cancer Institute, Bethesda, MD
6 · The paper itself

Abstract

Costello syndrome (CS) is a rare RASopathy that is typically associated with mild to moderate cognitive impairment. Based on detailed neuropsychological testing, this case series describes variability in the neurobehavioral presentations of three unrelated individuals with different pathogenic HRAS variants that cause CS. Results demonstrate a wide range of functioning among people with CS (extremely low to superior ranges) and describe the first cognitive testing results for an individual with HRAS c.179G>A, p.Gly60Asp. Patient-reported social, emotional, and quality of life outcomes also are discussed. These cases highlight the potential for above average cognitive functioning, the importance of flexible neurobehavioral assessment methods, and key quality of life and mental health domains to evaluate in individuals with CS.

Indexed as

Costello SyndromeNeurobehavioral ManifestationsProto-Oncogene Proteins p21(ras)AdolescentAdultChildFemaleHumansMaleMutationNeuropsychological TestsPhenotypeQuality of LifeHRAS protein, humanProto-Oncogene Proteins p21(ras)case reportcognitionCostello syndromeemotionalsocial

Identifiers

PMID41578731
PMCPMC12879293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.